Larry Dillaha's Net Worth
$9.38 Million
Who is Larry Dillaha?
Larry Dillaha has an estimated net worth of $9.38 Million. This is based on reported shares across multiple companies, which include FIRST HORIZON PHARMACEUTICAL CORP, Insys Therapeutics, Inc., and REPROS THERAPEUTICS INC..
SEC CIK
Larry Dillaha's CIK is 0001360463
Past Insider Trading and Trends
2014 was Larry Dillaha's most active year for acquiring shares with 3 total transactions. Larry Dillaha's most active month to acquire stocks was the month of February. 2014 was Larry Dillaha's most active year for disposing of shares, totalling 13 transactions. Larry Dillaha's most active month to dispose stocks was the month of February. 2007 saw Larry Dillaha paying a total of $704,000.00 for 32,000 shares, this is the most they've acquired in one year. In 2014 Larry Dillaha cashed out on 299,864 shares for a total of $11,179,762.39, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
FIRST HORIZON PHARMACEUTICAL CORP No price found
EVP and Chief Medical OfficerLarry Dillaha owns 74,511 units of Common.acquired a total of 72,000 shares in FIRST HORIZON PHARMACEUTICAL CORP at a cost of $1,598,500.00, Larry also disposed a total of 11,489 shares of FIRST HORIZON PHARMACEUTICAL CORP equalling to $279,460.83.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.16% | -875.00 |
$20.34 | -$17,794.00 | 74.51K |
Scheduled
|
Aug 11
| ||
Form 4
| -0.46% | -350.00 |
$19.35 | -$6,772.50 | 75.39K |
Scheduled
|
Apr 25
| ||
Form 4
| -1.14% | -875.00 |
$22.54 | -$19,722.50 | 75.74K |
Scheduled
|
Feb 20
| ||
Form 4
| -0.57% | -438.00 |
$22.44 | -$9,827.01 | 76.61K |
Scheduled
|
Jan 23
| ||
Form 4
| -3.22% | -2.56K |
$22.75 | -$58,308.25 | 77.05K |
Scheduled
|
Dec 7
| ||
Form 4
| +67.21% | 32K |
$22.00 | $704,000.00 | 79.61K |
Dec 5
| |||
Form 4
| -6.85% | -3.50K |
$28.00 | -$98,000.00 | 47.61K |
Scheduled
|
Oct 10
| ||
Form 4
| -1.68% | -875.00 |
$23.50 | -$20,562.50 | 51.11K |
Aug 9
| |||
Form 4
| -0.62% | -325.00 |
$25.07 | -$8,147.75 | 51.99K |
Apr 25
| |||
Form 4
| -3.13% | -1.69K |
$23.89 | -$40,326.32 | 52.31K |
Feb 21
| |||
Form 4
| +125.00% | 30K |
$23.28 | $698,400.00 | 54K |
Dec 7
| |||
Form 4
| +71.43% | 10K |
$19.61 | $196,100.00 | 24K |
Aug 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Insys Therapeutics, Inc. No price found
Chief Medical OfficerLarry Dillaha owns 3,125 units of Common Stock. In the year 2013 Larry Dillaha filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$38.88 | -$10,702,926.07 | 3.13K |
Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REPROS THERAPEUTICS INC. No price found
Interim President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||